Role of dyslipidemia in ischemic stroke patients treated in the telestroke network

The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify...

Full description

Saved in:
Bibliographic Details
Published in:Advances in medical sciences 2021-09, Vol.66 (2), p.254-261
Main Authors: Brechtel, Leanne, Poupore, Nicolas, Monroe, Margaret, Knisely, Krista, Sanders, Carolyn, Edrissi, Camron, Rathfoot, Chase, Nathaniel, Thomas I.
Format: Article
Language:English
Subjects:
Brain Ischemia - complications
Dyslipidemia
Dyslipidemias - complications
Dyslipidemias - epidemiology
Humans
Ischemic Stroke
Neurologic outcome
NIHSS score
Retrospective Studies
Risk Factors
Stroke
Stroke - complications
Telestroke
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The relationship between the telestroke technology and clinical risk factors in a dysplipidemic ischemic stroke population and neurologic outcomes is not fully understood. This issue was investigated in this study. We analyzed retrospective data collected from a regional stroke registry to identify demographic and clinical risk factors in patients with improving (NIHSS ​≤ ​7) or worsening (NIHSS ​> ​7) neurologic outcome in dyslipidemic ischemic stroke population. We used logistic multivariate models to identify independent predictors of improving or worsening outcome based on dyslipidemia disease status in ischemic stroke patients. In the adjusted analysis for dyslipidemic ischemic stroke population, cholesterol reducer use (odd ratio; [OR] ​= ​0.393, 95% confidence interval [CI], 0.176–0.879, P ​= ​0.023) and direct admission (OR ​= ​0.435, 95% CI, 0.199–0.953, P ​= ​0.037) were more likely to be associated with neurologic improvement and no clinical or demographic factors were associated with poor neurologic outcome in dyslipidemic ischemic stroke patients treated in the telestroke network. For the ischemic stroke population without dyslipidemia, increasing age (OR ​= ​1.070, 95% CI, 1.031–1.109, P ​
ISSN:1896-1126
1898-4002
DOI:10.1016/j.advms.2021.04.003